Skip to main content
. 2018 Nov 13;42(2):zsy217. doi: 10.1093/sleep/zsy217

Table 1.

Sample characteristics prior to treatment (n = 150)

Sample size All participants SHE SRT CBTI
150 50 50 50
Age 56.44 ± 5.64 years 57.24 ± 5.55 years 56.76 ± 5.39 years 55.32 ± 5.90 years F (2,147) = 1.58, p = .21
Race
 White 78; 52.0% 26; 52.0% 28; 56.0% 24; 48.0%
 Black 59; 39.3% 20; 40.0% 17; 34.0% 22; 44.0%
 Hispanic or Latinx 1; 0.7% 1; 2.0%
 Multiracial 1; 0.7% 1; 2.0%
 Other 2; 1.3% 1; 2.0% 1; 2.0%
 Did not answer 9; 6.0% 3; 6.0% 3; 6.0% 3; 6.0%
Hormone replacement therapy 4; 2.7% 3; 6.0% 1; 2.0% 0; 0.0%
Medical menopause 35; 23.3% 9; 18.0% 12; 24.0% 14; 28.0%
Years since last menstruation 7.12 ± 7.04 7.33 ± 7.79 6.93 ± 6.79 7.09 ± 6.65 F(2,147) = 0.04, p = .96
FIRST 21.86 ± 6.05; 73.8% 22.73 ± 6.53; 75.0% 21.08 ± 4.95; 75.5% 21.79 ± 6.58; 70.8% F(2,147) = 0.90, p=.41
Pretreatment
 ISI 15.17 ± 3.98; 88.7% 15.36 ± 4.36; 86.0% 15.20 ± 3.67; 88.0% 14.94 ± 3.97; 92.0% F(2,147) = 0.14, p = .87
 Total sleep time 5 hr 46 m ± 77 m 5 hr 47 m ± 77 m 5 hr 27 m ± 74 m 6 hr 5 m ± 77 m F(2,132) = 2.94, p = .06
 Sleep quality 2.96 ± .54; Fair 3.01 ± .50; Fair 2.87 ± .54; Fair 3.02 ± .57; Fair F(2,134) = 1.14, p = .32
 Sleep latency 30.83 ± 18.15; 42.3% 28.37 ± 12.40; 34.1% 34.86 ± 23.82; 46.8% 29.06 ± 15.60; 45.7% F(2,134) = 1.80, p = .17
 Nighttime awakenings 2.75 ± 1.24 2.93 ± 1.35 2.59 ± .99 2.73 ± 1.35 F(2,134) = 0.91, p = .40
 Wake after sleep onset 57.72 ± 36.27; 75.2% 61.83 ± 39.50; 79.5% 62.33 ± 37.02; 78.7% 49.07 ± 31.14; 67.4% F(2,134) = 2.00, p = .14
 Sleep efficiency 71% ± 15% 72% ± 14% 69% ± 14% 75% ± 13% F(2,132) = 2.79, p = .07

FIRST = ford insomnia response to stress test. Medical menopause = menopause due to medical treatments including complete or partial hysterectomy, chemotherapy, or endometrial ablation.

ISI % is proportion that is ISI ≥ 11. All other sleep parameters collected using the consensus sleep diary. One-way ANOVAs used to compare pretreatment means, with Bonferroni post hoc comparisons.